Expertise in
18
conditions

Dr. Kenneth B. Margulies

Cardiology
3400 Civic Center Boulevard, East Pavilion, 2nd Floor, 
Philadelphia, PA 
Accepting New Patients
Referral may be required
Before you request
Expertise in
18
conditions
3400 Civic Center Boulevard, East Pavilion, 2nd Floor, 
Philadelphia, PA 

Overview

Kenneth Margulies is a Cardiologist practicing medicine in Philadelphia, Pennsylvania.

Dr. Margulies is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Cardiomyopathy, Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Transplant, and Cardiac Ablation.

Dr. Margulies is board certified in Advanced Heart Failure And Transplant Cardiology, 2010, Internal Medicine, 1989, and Cardiovascular Disease, 1993. He is actively involved in clinical research, co-authoring 267 peer reviewed articles and participating in 8 clinical trials. Dr. Margulies is currently accepting new patients.

Specialties

Cardiology

Licenses

Transplant Surgery in PA

Board Certifications

Advanced Heart Failure And Transplant Cardiology, 2010
Internal Medicine, 1989
Cardiovascular Disease, 1993

Fellowships

Mayo Clinic

Hospital Affiliations

Hospital Of Univ Of Pennsylvania

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Avalon Health Care
  • MEDICARE PDP
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Geisinger
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Johns Hopkins Healthcare
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Provider Partners Health Plan
  • MEDICARE SNP
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 23 Less Insurance Carriers -

Locations

Penn Heart and Vascular Center
3400 Civic Center Boulevard, East Pavilion, 2nd Floor, Philadelphia, PA 19104

Additional Areas of Focus

Dr. Margulies has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Cor Pulmonale
Pulmonary Edema
Heart Failure
Giant Cell Myocarditis
Cardiomyopathy
Arrhythmogenic Right Ventricular Cardiomyopathy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Randomized, Double-Blind, Placebo-controlled, Single-ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of JK07 in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF)
A Randomized, Double-Blind, Placebo-controlled, Single-ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of JK07 in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF)
Enrollment Status: Completed
Publish Date: July 09, 2025
Intervention Type: Drug
Study Drug: JK07
Study Phase: Phase 1
Electrogram-Guided Myocardial Advanced Phenotyping (The eMAP Trial)
Electrogram-Guided Myocardial Advanced Phenotyping (The eMAP Trial)
Enrollment Status: Terminated
Publish Date: April 06, 2025
Intervention Type: Device
A Study to Evaluate Lung Ultrasound as a Method to Measure Changes in Extravascular Lung Water Induced by Positional Changes or Exercise in Patients Stabilized Following Hospitalization for Acute Decompensated Heart Failure
A Study to Evaluate Lung Ultrasound as a Method to Measure Changes in Extravascular Lung Water Induced by Positional Changes or Exercise in Patients Stabilized Following Hospitalization for Acute Decompensated Heart Failure
Enrollment Status: Completed
Publish Date: December 21, 2023
Intervention Type: Other
Study Phase: Not Applicable
Effect of Dapagliflozin on Submaximal Exercise Tolerance in Heart Failure
Effect of Dapagliflozin on Submaximal Exercise Tolerance in Heart Failure
Enrollment Status: Completed
Publish Date: December 12, 2023
Intervention Type: Drug
Study Drug: Dapagliflozin
Study Phase: Phase 2
EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study)
EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study)
Enrollment Status: Completed
Publish Date: December 03, 2021
Intervention Type: Drug
Study Phase: Phase 4
A Phase 2 Open-label Pilot Study to Evaluate Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of MYK-461 in Subjects With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction
A Phase 2 Open-label Pilot Study to Evaluate Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of MYK-461 in Subjects With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction
Enrollment Status: Completed
Publish Date: June 08, 2021
Intervention Type: Drug
Study Phase: Phase 2
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Enrollment Status: Completed
Publish Date: March 13, 2019
Intervention Type: Drug
Study Phase: Phase 2
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Enrollment Status: Terminated
Publish Date: January 23, 2019
Intervention Type: Combination product
Study Phase: Phase 2
View 7 Less Clinical Trials

265 Total Publications

SGLT2 inhibitors activate pantothenate kinase in the human heart.
SGLT2 inhibitors activate pantothenate kinase in the human heart.
Journal: Science (New York, N.Y.)
Published: August 27, 2026
Similar Doctors
Expertise in
30
conditions
Expertise in
30
conditions
Referral may be required
Before you request

Penn Heart And Vascular Center

3400 Civic Center Boulevard, East Pavilion, 2nd Floor, 
Philadelphia, PA 
 (0.1 miles away)
800-789-7366
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

David Callans is a Cardiologist practicing medicine in Philadelphia, Pennsylvania. Dr. Callans is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Ventricular Tachycardia, Arrhythmias, Cardiomyopathy, Cardiac Ablation, and Pacemaker Implantation. Dr. Callans is board certified in Internal Medicine, 1989, Clinical Cardiac Electrophysiology, 1994, and Cardiovascular Disease, 1993. Dr. Callans is currently accepting new patients.

Expertise in
39
conditions
Expertise in
39
conditions
Referral may be required
Before you request

Penn Heart And Vascular Center

3400 Civic Center Boulevard, East Pavilion, 2nd Floor, 
Philadelphia, PA 
 (0.1 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Saman Nazarian is a Cardiologist practicing medicine in Philadelphia, Pennsylvania. Dr. Nazarian is highly rated in 39 conditions, according to our data. His clinical expertise encompasses Ventricular Tachycardia, Arrhythmias, Atrial Fibrillation, Cardiac Ablation, and Pacemaker Implantation. Dr. Nazarian is board certified in Cardiovascular Disease, 2006 and Clinical Cardiac Electrophysiology, 2008. Dr. Nazarian is currently accepting new patients.

Expertise in
24
conditions
Dr. Daniel J. Rader
Cardiology | Medical Genetics
Expertise in
24
conditions
Dr. Daniel J. Rader
Cardiology | Medical Genetics
Referral may be required

Penn Translational Medicine And Human Genetics

3400 Civic Center Boulevard, South Pavilion, 1st Floor, 
Philadelphia, PA 
 (0.1 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Daniel Rader is a Cardiologist and a Medical Genetics provider practicing medicine in Philadelphia, Pennsylvania. Dr. Rader is highly rated in 24 conditions, according to our data. His clinical expertise encompasses High Cholesterol, Homozygous Familial Hypercholesterolemia (HoFH), Coronary Heart Disease, Hypolipoproteinemia, and Heart Transplant. Dr. Rader is board certified in Internal Medicine, 1987. Dr. Rader is currently accepting new patients.

Frequently Asked Questions about Dr. Kenneth B. Margulies

How do I make an appointment with Dr. Kenneth B. Margulies?

You can book an appointment with Dr. Kenneth B. Margulies by calling their office at 215-615-4949. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Kenneth B. Margulies a top-rated expert for Cardiomyopathy?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Kenneth B. Margulies is classified as an Elite expert for Cardiomyopathy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Kenneth B. Margulies specialize in?

While Dr. Kenneth B. Margulies is a Cardiology, they have specific expertise in Cardiomyopathy, Heart Failure, and Heart Failure with Preserved Ejection Fraction (HFpEF). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Cardiology.

Does Dr. Kenneth B. Margulies participate in research or clinical trials?

Yes. Dr. Kenneth B. Margulies has published 265 articles and abstracts on conditions like Cardiomyopathy. You can view a list of Dr. Kenneth B. Margulies's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Kenneth B. Margulies accept my insurance?

Dr. Kenneth B. Margulies accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 215-615-4949 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Margulies's expertise for a condition
ConditionClose
View All 11 Advanced Conditions
View All 44 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile